Checchi Capital Advisers, LLC Invitae Corp Transaction History

Checchi Capital Advisers, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$24.31 - $33.6 $196,157 - $271,118	-8,069 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$26.09 - $40.4 $5,870 - $9,090	225 Added 2.87%	8,069 $272,000
Q1 2021 May 10, 2021	SELL	$33.06 - $56.93 $2,710 - $4,668	-82 Reduced 1.03%	7,844 $300,000
Q4 2020 Feb 12, 2021	SELL	$39.09 - $57.4 $22,515 - $33,062	-576 Reduced 6.77%	7,926 $331,000
Q3 2020 Nov 10, 2020	BUY	$28.43 - $44.67 $568 - $893	20 Added 0.24%	8,502 $369,000

Q2 2020 Aug 12, 2020	BUY	$11.71 - $30.29 $99,324 - $256,919	8,482 New	8,482 $257,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Checchi Capital Advisers, LLC with notifications on news.